Current Status and Emerging Trends in Colorectal Cancer Screening and Diagnostics
Open accessThe DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Abstract
Colorectal cancer (CRC) is a prevalent and potentially fatal disease categorized based on its high incidences and mortality rates, which raised the need for effective diagnostic strategies for the early detection and management of CRC. While there are several conventional cancer diagnostics available, they have certain limitations that hinder their effectiveness. Significant research efforts are currently being dedicated to elucidating novel methodologies that aim at comprehending the intricate molecular mechanism that underlies CRC. Recently, microfluidic diagnostics have emerged as a pivotal solution, offering non-invasive approaches to real-time monitoring of disease progression and treatment response. Microfluidic devices enable the integration of multiple sample preparation steps into a single platform, which speeds up processing and improves sensitivity. Such advancements in diagnostic technologies hold immense promise for revolutionizing the field of CRC diagnosis and enabling efficient detection and monitoring strategies. This article elucidates several of the latest developments in microfluidic technology for CRC diagnostics. In addition to the advancements in microfluidic technology for CRC diagnostics, the integration of artificial intelligence (AI) holds great promise for further enhancing diagnostic capabilities. Advancements in microfluidic systems and AI-driven approaches can revolutionize colorectal cancer diagnostics, offering accurate, efficient, and personalized strategies to improve patient outcomes and transform cancer management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




![Figure 5 Schematic illustration (A1,A2) Integrated microfluidic device for CTC enrichment and analysis (B1,B2) Development of Integrated Microfluidic Device for Simultaneous Enrichment and Analysis of Circulating Tumor Cells, (C1) Comparative Immuno-staining Analysis of Captured Cells in PBS and Human Blood Samples [81]. (Reproduced with permission from Su, W.; Yu, H.; Jiang, L.; Chen, W.; Li, H.; Qin, J, Disease Markers; published by Hindawi, 2019).](https://figures.cochat.ai/paper-figures/1fd715b4e8834ceca3a27c166a357f64/current-status-and-emerging-trends-in-colorectal-cancer-screening-and-figure-5.jpg)
![Figure 6 Schematic representation illustrating the underlying mechanism of enzyme-aided fluorescence amplification based on GO-DNA aptamer interactions for exosome detection (Image taken from: Reproduced with permission from Wang, H.; Chen, H.; Huang, Z.; Li, T.; Deng, A.; Kong, J. Ta-lanta; published by Elsevier, 2018 [87].](https://figures.cochat.ai/paper-figures/82bd840d41c14274bae7fb6369102714/current-status-and-emerging-trends-in-colorectal-cancer-screening-and-figure-6.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global colorectal cancer burden in 2020 and projections to 2040
Xi, Y., & Xu, P. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101174 · Cited by 2,434 · cited 1×
“Recent epidemiological data from 2020 to 2021 reported a mortality rate of 9.4%, accompanied by a noteworthy increase in incidents among the elderly [2].”
BackgroundInfluentialEpidemiology of colorectal cancer: incidence, mortality, survival, and risk factors
Rawla, P., Sunkara, T., & Barsouk, A. (2019) · Gastroenterology Review · doi:10.5114/pg.2018.81072 · Cited by 2,323
Microfluidic diagnostic technologies for global public health
Yager, P., Edwards, T., Fu, E., Helton, K., Nelson, K., Tam, M. R., & Weigl, B. H. (2006) · Nature · doi:10.1038/nature05064 · Cited by 1,979
Multitarget Stool DNA Testing for Colorectal-Cancer Screening
Imperiale, T. F., Ransohoff, D. F., Itzkowitz, S. H., Levin, T. R., Lavin, P., Lidgard, G. P., Ahlquist, D. A., & Berger, B. M. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311194 · Cited by 1,900 · cited 1×
“…can identify specific molecular changes that are indicative of CRC or By analyzing alterations in genes or DNA regions known to be linked to CRC, these tests can identify speci fi c molecular changes that are indicative of CRC or advanced adenomas. biomarkers associated with CRC development [21].”
BackgroundTrevethan, R. (2017) · Frontiers in Public Health · doi:10.3389/fpubh.2017.00307 · Cited by 1,616
Ethical and legal challenges of artificial intelligence-driven healthcare
Gerke, S., Minssen, T., & Cohen, G. (2020) · Artificial Intelligence in Healthcare · doi:10.1016/b978-0-12-818438-7.00012-5 · Cited by 1,170 · cited 1×
“Addressing these concerns effectively is imperative to facilitate adoption [111].”
BackgroundLin, J. S., Bowles, E. J. A., Williams, S. B., & Morrison, C. C. (2017) · JAMA · doi:10.1001/jama.2017.0562 · Cited by 1,082
Accuracy of Fecal Immunochemical Tests for Colorectal Cancer: Systematic Review and Meta-analysis
Lee, J. K., Liles, E. G., Bent, S., Levin, T. R., & Corley, D. A. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1484 · Cited by 707 · cited 1×
“…demonstrates up to 79% sensitivity and 94% specificity, reflecting its efficacy as a screening modality for detecting CRC prior to symptoms [19] and contributing to Among these, FIT demonstrates up to 79% sensitivity and 94% speci fi city, re fl ecting its e ffi cacy as a robust screening…”
BackgroundLin, J. S., Piper, M. A., Perdue, L. A., Rutter, C. M., Webber, E. M., O’Connor, E., Smith, N., & Whitlock, E. P. (2016) · JAMA · doi:10.1001/jama.2016.3332 · Cited by 693
Colorectal cancer screening: An updated review of the available options
Issa, I. A., & Noureddine, M. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i28.5086 · Cited by 572
Research works printed but not linked: 2
- Raut N.S. Umekar M.J. Dhoble S.J. 18—Quantum dots: Novel approach for biological imaging Quantum Dots Thejo Kalyani N. Dhoble S.J. Michalska-Domańska M. Vengadaesvaran B. Nagabhushana H. Arof A.K. Woodhead Publishing Series in Electronic and Optical Materials Woodhead Publishing Cambridge, UK 2023 477 500 978-0-323-85278-4
- Palei N.N. Mohanta B.C. Sabapathi M.L. Das M.K. Chapter 10—Lipid-based nanoparticles for cancer diagnosis and therapy Organic Materials as Smart Nanocarriers for Drug Delivery Grumezescu A.M. William Andrew Publishing Norwich, NY, USA 2018 415 470 978-0-12-813663-8
Cited by
Liquid biopsy in cancer management: Integrating diagnostics and clinical applications
Pandey, S., & Yadav, P. K. (2024) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2024.e00446 · Cited by 131
Hemdan, M., Abuelhaded, K., Shaker, A. A. S., Ashour, M. M., Abdelaziz, M. M., Dahab, M. I., Nassar, Y. A., Sarguos, A. M. M., Zakaria, P. S., Fahmy, H. A., et al. (2025) · Sensing and Bio-Sensing Research · doi:10.1016/j.sbsr.2025.100783 · Cited by 56
Eslami, M., Naderian, R., Bahar, A., Babaeizad, A., Gheshlagh, S. R., Oksenych, V., & Tahmasebi, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1559480 · Cited by 60
Risk factors, prevention and screening of colorectal cancer: A rising problem
Tsukanov, V. V., Vasyutin, A. V., & Tonkikh, J. L. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i5.98629 · Cited by 42
AI-powered liquid biopsy for early detection of gastrointestinal cancers
Hussain, M. S., Rejili, M. S., Khan, A., Alshammari, S. O., Tan, C. S., Haouala, F., Ashique, S., & Alshammari, Q. A. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120484 · Cited by 31
Azarian, M., Farani, M. R., Cho, W. C. S., Asgharzadeh, F., Yang, Y.-J., Binabaj, M. M., Tambuwala, M. M., Farahani, N., Hushmandi, K., & Huh, Y. S. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155706 · Cited by 24
Unraveling the complexities of colorectal cancer and its promising therapies – An updated review
Saha, S., Ghosh, S., Ghosh, S., Nandi, S., & Nayak, A. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113325 · Cited by 30
Raseena, T. P., Kumar, J., & Balasundaram, S. R. (2024) · SN Computer Science · doi:10.1007/s42979-024-02825-1 · Cited by 14
“Established screening methods such as Colonoscopy, FOBT, and Biopsies, while effective, are hindered by drawbacks, including invasiveness, time consumption, and high costs [11].”
Novel drug delivery systems in colorectal cancer: Advances and future prospects
Kamal, R., Awasthi, A., Paul, P., Mir, M. S., Singh, S. K., & Dua, K. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155546 · Cited by 16
Masrour, M., Khanmohammadi, S., Habibzadeh, A., & Fallahtafti, P. (2024) · PLoS ONE · doi:10.1371/journal.pone.0308009 · Cited by 14
Small nucleolar RNA and its potential role in the oncogenesis and development of colorectal cancer
Lan, Y.-Z., Wu, Z. Q., Chen, W.-J., Fang, Z.-X., Yu, X., Wu, H.-T., & Liu, J. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i2.115 · Cited by 14
“The application of high-quality microarrays and high-throughput sequencing has unequivocally demonstrated differential snoRNA expression in clinical samples and cell lines, implying diagnostic and prognostic potential in CRC[54,92].”
InfluentialFadel, M. G., Zonoobi, E., Luna, M. R. R., Mishima, K., Ris, F., Diana, M., Vahrmeijer, A. L., Perretta, S., Ashrafian, H., & Fehervari, M. (2024) · Cancers · doi:10.3390/cancers16193377 · Cited by 11
“Colorectal cancer (CRC) imposes a significant global health burden, with escalating incidence rates worldwide [1,2].”
BackgroundLong non‑coding RNAs as diagnostic and prognostic biomarkers for colorectal cancer (Review)
Lin, Y., Zhao, W., Pu, R., Lv, Z., Hongyan, X., Li, Y., & Zhang, Z. (2024) · Oncology Letters · doi:10.3892/ol.2024.14619 · Cited by 12
“However, neither method can reveal the exact location of the lesions, and they have relatively high false‑positive and false‑negative rates (3).”
MethodChuang, P.-K., Chang, K.-F., Chang, C.-H., Chen, T., Wu, Y., Lin, H.-R., Wu, C.-J., Wu, C., Ho, Y., Lin, C., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041648 · Cited by 12
Stool Glycoproteomics Signatures of Pre-Cancerous Lesions and Colorectal Cancer
Soares, J., Eiras, M., Ferreira, D., Santos, D. A. R., Relvas‐Santos, M., Santos, B., Gonçalves, M., Ferreira, E., Vieira, R., Afonso, L. P., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073722 · Cited by 8
“Furthermore, it may serve as a valuable tool for monitoring CRC patients undergoing treatment, aiding in response assessment and disease progression monitoring [2,7].”
MethodLu, P., Su, X., Leong, S., Xiu, X., Song, P., Peng, J., & Si, Y. (2025) · Biosensors · doi:10.3390/bios15050308 · Cited by 8
“Colorectal cancer (CRC) is the third most common malignant tumor globally and the second leading cause of cancer-related death [1–3].”
Liu, Q., Li, X., Jin, T., Huo, S., Su, S., & Liu, N. (2025) · Diagnostic Cytopathology · doi:10.1002/dc.70009 · Cited by 10
“Early detection significantly improves prognosis and survival rates, yet traditional screening methods—such as colonoscopy, fecal occult blood testing (FOBT), and stool DNA testing—face limitations in accessibility, compliance, and sensitivity, particularly for early-stage disease [63–67].”
Recent advances in DNA nanotechnology for cancer detection and therapy: A review
Esmaeilpour, D., Ghomi, M., Zare, E. N., & Sillanpää, M. E. T. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142136 · Cited by 9
Photoacoustic-Integrated Multimodal Approach for Colorectal Cancer Diagnosis
Biswas, S., Chohan, D. P., Wankhede, M., Rodrigues, J., Bhat, G., Mathew, S., & Mahato, K. K. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c00918 · Cited by 7
Ghoytasi, I., Bavi, O., Mofrad, M. R. K., & Naghdabadi, R. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108744 · Cited by 6
Qiu, Z., Cheng, Y., Liu, H., Li, T., Jiang, Y., Yin, L., Jiang, D., Zhang, X., Wang, X., Kang, Z., et al. (2025) · BMC Cancer · doi:10.1186/s12885-025-14080-5 · Cited by 7
“Conventional clinical tumor markers, such as CEA and CA19-9, shows limited sensitivity, furtherly highlighting the potential need for more efficient and patient-friendly diagnosis options [10–12].”
Addressing Gaps in Colorectal Cancer Screening: The Role of Patient Navigation and Future Directions
Lieberman, D. A., Doubeni, C. A., & Howard, D. E. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2025.05.023 · Cited by 6
Gonal, B. N., Dalbanjan, N. P., Kadapure, A. J., Kumar, S. K. P., & Arakera, S. B. (2025) · Animals and zoonoses. · doi:10.1016/j.azn.2025.12.001 · Cited by 6
Devan, S.-B. S., Ramli, R., Alshehade, S. A., Lim, S. Y. M., & MAMAT, N. B. (2024) · Analytical Biochemistry · doi:10.1016/j.ab.2024.115748 · Cited by 5
Hashemzadeh, H., Eshkiki, Z. S., Kelkawi, A. H. A., Rafati, N., Gaaib, J. N., Agah, S., Tabaeian, S. P., Beigi, S. N., Namazi, A., Akbari, A., et al. (2026) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217556 · Cited by 4
Wang, L., Xu, Z., Bains, A., Ali, N., Shang, Z., PATIL, A. R., & Patil, S. (2024) · Biologics · doi:10.2147/btt.s477602 · Cited by 7
Identification and Validation of Serum Biomarkers to Improve Colorectal Cancer Diagnosis
Yoon, M. L., Chun, H., Lee, H., Seo, W., Lee, J. Y., & Yoon, J. H. (2024) · Cancer Medicine · doi:10.1002/cam4.70460 · Cited by 4
“Existing biomarkers for colon cancer, such as Carbohydrate Antigen 19-9 (CA19-9) and Carcinoembryonic Antigen (CEA), are also widely used as biomarkers for CRC diagnosis [3–6].”
Ibrahim, R. S., El‐Wadood, H. M. A., El‐Zahry, M. R., & Hosny, N. M. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.113137 · Cited by 4
Caldevilla, R., Eiras, M., Santos, D. A. R., Almeida, J. V. S., Oliveira, M. B. P. P., Loureiro, S., Soares, J., González‐Santos, M., Ramos, N., Videira, P. A., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073070 · Cited by 4
Oxidative Stress Assessment in Colorectal Cancer Patients: Erbil Population Study
Qadir, V. A., & Abdoulrahman, K. (2024) · ARO-The Scientific Journal of Koya University · doi:10.14500/aro.11526 · Cited by 4
Leveraging cfDNA fragmentomic features for the early detection of colorectal cancer
Shan, L., Xu, D., Chen, J., Liu, W., Lin, J., Bao, J., Huang, J., Zhang, H., Zhao, H., Xue, W., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1705156 · Cited by 3
Allahqoli, L., Mazidimoradi, A., Rezaei, F., Pasokh, Z., Hakimi, S., Momenimovahed, Z., Aghamohammadi, S. Z., Rahmani, A., Fallahi, A., Karimzadeh, A., et al. (2024) · Indian Journal of Gynecologic Oncology · doi:10.1007/s40944-024-00915-9 · Cited by 3
“This change may reflect both the aging global population and evolving risk factors in different age cohorts [22, 25, 26].”
Lee, D., Ahn, K., Yun, K., Oh, Y., Park, Y. S., Kim, Y. S., Gim, J., Mun, S., Mun, J.-Y., Han, K., et al. (2024) · Beneficial Microbes · doi:10.1163/18762891-bja00051 · Cited by 4
Phan, K. S., Doan, B., Wang, Y., Le, T. T. H., Mai, T. T. T., Pham, H. N., Bui, H. B. H., Dang, L. H., Trân, N. Q., & Ha, P. T. (2025) · Biomaterials Science · doi:10.1039/d5bm00659g · Cited by 2
Le, D. T. P., & Pham, T. D. (2025) · Exploration of Medicine · doi:10.37349/emed.2025.1001371 · Cited by 5
Sebzda, T., Karwacki, J., Cichoń, A., Modrzejewska, K., Heimrath, J., Łątka, M., Gnus, J. J., & Gburek, J. (2024) · Cancers · doi:10.3390/cancers16132471 · Cited by 2
“Biomarkers play a pivotal role in this context, offering potential tools for early detection, prognosis, and monitoring therapeutic responses [35].”
BackgroundNanoimaging techniques for gastrointestinal visualization
Abady, M. M., Mohammed, D. M., Imtiaz, S., Imtiaz, S., & Sakr, F. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-34039-0.00003-2 · Cited by 1
Biophysical approaches to cancer diagnostics: Collagen biomarkers in colorectal cancer
Biswas, S., & Mahato, K. K. (2026) · Physics of Life Reviews · doi:10.1016/j.plrev.2026.01.009 · Cited by 2
Ulusu, F., Özel, S. S., Sarılmaz, A., & Ulusu, Y. (2026) · Journal of Sol-Gel Science and Technology · doi:10.1007/s10971-025-07078-9 · Cited by 1
“Despite these advancements, colorectal adenocarcinoma remains a leading cause of cancer-related death worldwide, underscoring the importance of ongoing research into innovative therapeutic strategies and early detection methods [4].”
Saini, A., & Yadav, N. (2026) · Microchemical Journal · doi:10.1016/j.microc.2026.117718 · Cited by 1
Chen, M., Huang, S., Gong, L., Wu, X., Li, Y., & Wu, H. (2026) · Human Cell · doi:10.1007/s13577-026-01364-6 · Cited by 1
Cao, C., Tang, F., Zhu, Z., Wang, F., & Li, J. (2026) · PeerJ · doi:10.7717/peerj.21449 · Cited by 1
Advances in biomimetic nanomaterials for targeted drug delivery in colon cancer
Dharme, K. K., Jain, P., Verma, G., & Uddin, A. (2026) · Holistic Integrative Oncology · doi:10.1007/s44178-026-00279-4 · Cited by 1
“Due to their high atomic number, Ag NPs have been shown to increase tumour cells’ radio resistance through improved radiation absorption, causing cancer cells to be specifically destroyed [44, 46].”
Sharma, M., Dande, P. R., Saraf, A., Gawad, J., Maheshwari, R., & Ashique, S. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815305906125010015 · Cited by 1
Leveraging Artificial Intelligence for Colon Cancer: Trends, Challenges and Innovations
Takkar, S., & Rakhra, M. (2025) · International Conference on Automation and Computation (AUTOCOM) · doi:10.1109/autocom64127.2025.10956246
“These are technical issues like the scarcity of data and lack of interpretability of models and practical issues like integration into clinical workflows and ethical issues about patient privacy [8].”
Vaman, R. S. (2025) · Indian Journal of Community and Family Medicine · doi:10.4103/ijcfm.ijcfm_66_24
Cellular Membrane Engineering Platform for Capturing and Neutralizing Circulating Tumor Cells
Chen, C. (2025) · Springer eBooks · doi:10.1007/978-3-031-93425-4_12
Modern approaches to a colon polyposis early detection
Skuratova, O. S., Polosina, A. R., Stebleva, V. A., & Lagutina, S. N. (2025) · Russian Journal of Preventive Medicine · doi:10.17116/profmed20252807191
Balou, H. A., Joukar, F., Goorabzarmakhi, M. O., Shahdkar, M., Hassanipour, S., Maroufizadeh, S., Asgharnezhad, M., Karimian, P., & Mansour‐Ghanaei, F. (2025) · PubMed Central · doi:10.22088/cjim.16.3.451
Mesothelin in pancreatic cancer: clinical applications and analytical considerations
Patel, N. K., Gupta, A., Mishra, R., Menon, S. V., Ray, S., Pandey, S. N., Goyal, K., Ali, H., Maji, C., Rekha, A., et al. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120686
Wu, S. (2026) · Discover Oncology · doi:10.1007/s12672-026-05156-0
“Moreover, due to tumor heterogeneity, it is crucial to establish a systematic and precise method to stratify CRC risk [6, 7].”
Wang, Y., Chen, J., Arias, R., Wang, Y., & Yin, X. (2025) · International Conference on Public Health and Data Science (ICPHDS) · doi:10.1145/3789537.3789551
“Data integration is implemented via a hybrid communication protocol stack, utilizing BLE for dynamic signal transmission and HTTPS channels for structured health record uploads [2].”
Kamal, R., Chauhan, A., Singh, T. G., Dhiman, S., & Awasthi, A. (2026) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2026.2648023 · Cited by 1
“Although screening and multimodal management have made progress, CRC is often diagnosed at late stages, and, at this stage, therapeutic response is minimal, and prognosis is continuously poor [3,4].”
Iron biomarkers for prognosis, diagnosis, and therapeutic insight in colorectal cancer
Benamor, A., Kubatka, P., & Büsselberg, D. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119748 · Cited by 1
Revolutionizing colon cancer care: advances in carbon-based materials as theranostic agents
Kumar, R., Babu, M. M. H., Patel, S., Tripathi, A., Rahaman, S. A., & Gadewar, M. M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40443-6.00004-0
Intelligent Nanotechnology for Cancer Management: Prediction, Screening, and Diagnosis
Gayathiri, E., Shanmugam, J., Sankaranarayanan, N., Prakash, P., Kesavan, S., Sharmili, S. A., Mani, M., & Vijayakumar, S. (2026) · Smart nanomaterials technology · doi:10.1007/978-981-92-1690-1_4
Tyukanova, E. S., Fashafsha, Z. Z. A., Suvorov, A., Fatyanova, A. S., Ponomarev, V., Silantyev, A., Khlusov, D. I., Otabekov, A. A., Krasnov, Y. P., Волгин, М., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15186983
“However, its invasive nature, the need for bowel preparation, procedure-related discomfort, and limited adherence to screening programs restrict its effectiveness as a population-wide surveillance tool [3].”
Lu, J., Xuan, M., Yu, L., Xie, Z., Chu, Q., Wei, S., Wang, T., Xue, C., & Li, L. (2026) · MedComm · doi:10.1002/mco2.70994
Xu, Y., Zhang, H., Cai, Y., Zhou, C., Wang, P., Yu, L., Wang, Y., Liang, B., & Ye, X. (2026) · Chemical & Biomedical Imaging · doi:10.1021/cbmi.6c00152
Wang, L., Liu, Z., Zhu, Y., 戴, 松., Yang, Z., Liu, J., Dong, S., Li, Q., Li, Y., Liu, B., et al. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.154694
Metadata
- Authors
- Beniwal, S., Lamo, P., Kaushik, A., Lorenzo-Villegas, D., Liu, Y., & MohanaSundaram, A.
- Affiliations
- Lady Hardinge Medical College (IN)
- Universidad Internacional de La Rioja (ES)
- Florida Polytechnic University (US)
- Universidad Fernando Pessoa Canarias (ES)
- Mayo Clinic (US)
- Sathyabama Institute of Science and Technology (IN)
- Corresponding author
- Liu, Yuguang
- MohanaSundaram, ArunSundar
- ORCID
- Venue
- Biosensors
- Publisher
- MDPI AG
- Published
- 2023-10-13
- Volume
- 13
- Issue
- 10
- Pages
- 926
- ISSN
- 2079-6374 (ISSN-L)
- PMC
- PMC10605407
- OpenAlex
- W4387642583
- Semantic Scholar
- 83019e80b94cab903d85130811d1120c47c81c75
- Cited by
- 60
- References
- 112
- Citations by year
- 2026: 17 · 2025: 24 · 2024: 19
- FWCI
- 1.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biosensors (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Re-Unir (International University of La Rioja) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Physical Sciences › Engineering › Biomedical Engineering › Biosensors and Analytical Detection
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Bio-sensing Technologies
- Keywords
- colorectal cancer, cancer screening, cancer diagnosis, microfluidics, artificial intelligence, early detection, non-invasive diagnosis, treatment response monitoring
- MeSH terms
- Artificial Intelligence, Humans, Technology, Colorectal Neoplasms, Microfluidics, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.